Atlas Trials

Myxovirus Infection

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Myxovirus Infection

RecordFirmDate
Influenza Vaccine Revaccination in Ambulatory Elderly Subjects (NCT00775450)Sanofi Pasteur, a Sanofi Company2008-10-01
Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in Adults (NCT00772109)Sanofi Pasteur, a Sanofi Company2008-10-01
Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects (NCT00551031)Sanofi2007-10-01
Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects (NCT00845429)Sanofi2007-10-01
Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza Vaccines (NCT00776438)Sanofi Pasteur, a Sanofi Company2007-09-01
Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly (NCT00391053)Sanofi Pasteur, a Sanofi Company2006-10-01
Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children (NCT00391391)Sanofi2006-10-01
Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in Adults (NCT00383539)Sanofi Pasteur, a Sanofi Company2006-09-01
Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the Elderly (NCT00383526)Sanofi Pasteur, a Sanofi Company2006-09-01
Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly (NCT00296829)Sanofi Pasteur, a Sanofi Company2006-01-01
Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in Adults (NCT00703651)Sanofi Pasteur, a Sanofi Company2003-09-01

Track Myxovirus Infection automatically

Every clearance here is in the API, with alerts when new ones post.